The WACC of Bristol-Myers Squibb Co (BMY) is 5.9%.
| Range | Selected | |
| Cost of equity | 6.20% - 7.90% | 7.05% |
| Tax rate | 16.00% - 22.80% | 19.40% |
| Cost of debt | 4.00% - 4.60% | 4.30% |
| WACC | 5.3% - 6.6% | 5.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.5 | 0.55 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.20% | 7.90% |
| Tax rate | 16.00% | 22.80% |
| Debt/Equity ratio | 0.46 | 0.46 |
| Cost of debt | 4.00% | 4.60% |
| After-tax WACC | 5.3% | 6.6% |
| Selected WACC | 5.9% | |